Arachidonic acid and colorectal carcinogenesis

Molecular and Cellular Biochemistry

Volumn 253, Issue 1-2, 2003, Pages 141-149

  Jones, Raymond ^a   Adel Alvarez, Luis Alfonso ^b   Alvarez, Osvaldo Rascon ^c   Broaddus, Russell ^d   Das, Siddhartha ^a  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

^b BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE CIUDAD JUÁREZ   (Mexico)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Anti cancer drugs; Arachidonic acid; Colon cancer; Colorectal adenocarcinomas; Cyclooxygenase; Dietary lipids; Eicosanoid; Fatty acids; Oncogenes; Phospholipase; Phospholipase A2

Indexed keywords

ARACHIDONIC ACID; AZOXYMETHANE; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ICOSANOID; LINOLEIC ACID; LIPOXYGENASE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NABUMETONE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 6 FATTY ACID; PHOSPHOLIPASE A2; PROSTAGLANDIN SYNTHASE; SULINDAC; URSODEOXYCHOLIC ACID;

ADENOCARCINOMA; ANTINEOPLASTIC ACTIVITY; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CARCINOGENESIS; CAUSE OF DEATH; COLORECTAL CANCER; COLORECTAL CARCINOMA; COLORECTAL TUMOR; DIGESTIVE SYSTEM ULCER; DISEASE COURSE; ENZYME ACTIVITY; FAT INTAKE; HISTOPATHOLOGY; HUMAN; LIPID DIET; LIPID METABOLISM; MOLECULAR GENETICS; NEPHROTOXICITY; NONHUMAN; REGULATORY MECHANISM; REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; COLORECTAL NEOPLASMS; DIETARY FATS, UNSATURATED; HUMANS; LIPOXYGENASE; PHOSPHOLIPASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0142212372     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026060426569     Document Type: Review

References (96)

1. Awad AB, Chen Y, Fink CS, Hennessey T: β-sitosterol inhibits HT-29 human colon cancer cell growth and alters membrane lipids. Anticancer Res 16: 2797-2804, 1996
2. Chapkin RS, Fan Y, Lupton JR: Effect of diet on colonic-programmed cell death: Molecular mechanism of action. Toxicol Lett 112-113: 411-414, 2000
3. Gwyn K, Sinicrope FA: Chemoprevention of colorectal cancer. Am J Gastroenterol 97: 13-21, 2002
4. Levin B: Inflammatory bowel disease and colon cancer. Cancer 70: 1313, 1992
5. Riddell RH, Goldman RH, Ransohoff DF et al.: Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 14: 931, 1983
6. Sharma RA, Manson MM, Gescher A, Steward WP: Colorectal cancer chemoprevention: Biochemical targets and clinical development of promising agents. Eur J Cancer 37: 12-22, 2001
7. Bertram JS: The molecular biology of cancer. Mol Aspect Med 21: 167-223, 2001
8. Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, Goebell H et al.: Colorectal adenomas and diet, a case-control study. Dig Dis Sci 46: 86-95, 2001
9. Franceseschi S, Favero A: The role of energy and fat in cancers of the breast and colon-rectum in Southern European populations. Ann Oncol 10: S61-S63, 1999
10. Krause W, DuBois RN: Eicosanoids and the large intestine. Prostagland Lipid Mediat 61: 145-161, 2000
11. Thupari JN, Pinn ML, Kuhajda FP: Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. Biochim Biophys Acta 285: 217-223, 2001
12. Kuhajda FP: Fatty-acid synthase and human cancer: New perspectives on its role in tumor biology. Nutrition 16: 202-208, 2002
13. Rashid A, Pizer ES, Moga M, Milgraum LZ, Zahurak M, Pasternack GR, Kuhajda FP, Hamilton SR: Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 150: 201-208, 1997
14. Yang Y, Han WF, Morin PJ, Chrest FJ, Pizer ES: Activation of fatty acid synthesis during neoplastic transformation: Role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp Cell Res 279: 80-90, 2002
15. 2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276: 18075-18081, 2001
16. Marks F, Muller-Decker K, Furstenberger G: A causal relationship between unscheduled eicosanoid signaling and tumor development: Cancer chemoprevention by inhibitors of arachadonic acid metabolism. Toxicology 153: 11-26, 2000
17. Manson MM, Benford DJ: Factors influencing the carcinogenicity of food chemicals. Toxicology 134: 93-108, 1999
18. McIntosh GH, Le Leu RK: The influence of dietary proteins on colon cancer risk. Nutr Res 21: 1053-1066, 2001
19. Levi F, Pasche C, Lucchini F, La Vecchia C: Dietary fibre and the risk of colorectal cancer. Eur J Cancer 37: 2091-2096, 2001
20. Tsuda H, Sekine K, Ushida Y, Kuhura T, Takasuka N, Iigo M, Han BS, Moore MA: Milk and dietary products in cancer prevention: Focus on bovine lactoferrin. Mut Res 462: 227-233, 2000
21. Marchand LL, Wilkens LR, Hankin JH, Kolonel LN, Lyu L: A case-control study of diet and colorectal cancer in a multiethnic population in Hawaii (United States): Lipids and foods of animal origin. Cancer Caus Contr 8: 637-348, 1997
22. Davis PA, Iwahashi CK: Whole almonds and almond fractions reduce aberrant crypt foci in a rat model of colon carcinogenesis. Cancer Lett 165: 27-33, 2001
23. Greenwald P, Clifford CK, Milner JA: Diet and cancer prevention. Eur J Cancer 37: 948-965, 2001
24. Diggle CP: In vitro studies on the relationship between polyunsaturated fatty acids and cancer: Tumour or tissue specific effects? Prog Lipid Res 41: 240-253, 2002
25. Murray NR, Weems C, Chen L, Leon J, Yu W, Davidson LA, Jamison L, Chapkin RS, Thompson EA, Fields AP: Protein kinase CβII and TGFβRII in ω-3 fatty acid-mediated inhibition of colon carcinogenesis. J Cell Biol 157: 915-920, 2002
26. Urquhart P, Parkin SM, Rogers JS, Bosley JA, Nicolaou A: The effect of conjugated linoleic acid on arachidonic acid metabolism and eicosanoid production in human saphenous vein endothelial cells. Biochim Biophys Acta 1580: 150-160, 2002
27. McArthur MJ, Atshaves BP, Frolov A, Foxworth WD, Kier AB, Schroeder F: Cellular uptake and intracellular trafficking of long chain fatty acids. J Lipid Res 40: 1371-1383, 1999
28. Veerkamp JH, van Moerkerk HTB, Prinsen CFM, van Kuppevelt TH: Structural and functional studies on different human FABP types. Mol Cell Biochem 192: 137-142, 1999
29. Storch J, Thumser EAE: The fatty acid transport function of fatty acid binding proteins. Biochim Biophys Acta 1486: 28-44, 2000
30. Hertzel AV, Bernlohr DA: The mammalian fatty acid-binding protein multigene family: Molecular and genetic insights into function. Trends Endocrinol Metabol 11: 175-180, 2000
31. Woutersen RA, Appel MJ, van Garderen-Hoetmer A, Wijnands MVW: Dietary fat and carcinogenesis. Mut Res 443: 111-127, 1999
32. de Antueno RJ, Knickle LC, Smith H, Elliot ML, Allen SJ, Nowaka S, Winther MD: Activity of human Δ5 and Δ6 desaturases on multiple n-3 and n-6 polyunsaturated fatty acids. FEBS Lett 509: 77-80, 2001
33. Hansen-Petrik MB, McEntee MF, Johnson BT, Obukowicz MG, Masferrer J, Zqeifel B, Chiu C, Whelan J: Selective inhibition of Δ-6 desaturase impedes intestinal tumorigenesis. Cancer Lett 175: 157-163, 2002
34. Zhou L, Nillson A: Sources of eicosanoid precursor fatty acid pools in tissue. J Lipid Res 42: 1521-1542, 2001
35. Das S, Stevens T, Castillo C: Phospholipid remodeling/generation by Giardia: The role of the Lands Cycle. Trends Parasitol 17: 317-321, 2001
36. 2 enzymes in eicosanoid generation. Proc Assoc Am Physicians 111: 516-524, 1999
37. 2s in regulating arachidonic acid release. J Biol Chem 273: 14411-14423, 1998
38. 2 formation. J Surg Invest 1: 467-476, 2000
39. 2s . Biochim Biophys Acta 1488: 159-166, 2000
40. 2 increases with prostate tumor grade. Clin Cancer Res 7: 3857-3861, 2001
41. 2 induced prominent release of arachidonic acid from human myeloid leukemia cells. J Biol Chem 274: 34203-34211, 1999
42. Zhang H, Sun X: Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. Am J Gastroenterol 97: 1037-1041, 2002
43. Glinghammar B, Rafter J: Colonic luminal contents induce cyclooxygenase 2 transcription in human colon carcinoma cells. Gastroenterology 120: 401-410, 2001
44. Dannenberg AJ, Altorki NK, Boyle JO, Dang C, Howe LR, Weksler BB, Subbaramaiah K: Cyclo-oxygenase 2: A pharmacological target for the prevention of cancer. Lancet 2: 544-551, 2001
45. 716 knockout mice by inhibtion of cyclooxygenase 2 (PGHS-2). Cell 87: 803-809, 1996
46. Min-induced tumorigenesis. Proc Natl Acad Sci 98: 3935-3939, 2001
47. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP: Prostaglandins as modulators of immunity. Trends Immunol 23: 144-150, 2002
48. Pradono P, Tazawa R, Maemondo M, Tanaka M, Usui K, Saijo Y, Hagiwara K, Nukiwa T: Gene transfer of thromboxanes A (2) synthase and prostaglandin I (2) synthase antithetically altered tumor angiogenesis and tumor gtrowth. Cancer Res 62: 63-66, 2002
49. Stockton RA, Jacobson BS: Modulation of cell-substrate adhesion by arachidonic acid: Lipoxygenases regulates cell spreading and ERK1/2-inducible cyclooxygenase regulates cell migration in NIH3T3 fibroblasts. Mol Biol Cell 12: 1937-1956, 2001
50. Fukuda M, Hiraoka N, Yeh JC: C-type lectins and sialyl Lewis X oligosaccharides. Versatile roles in cell-cell interaction. J Cell Biol 147: 467-470, 1999
51. Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell 83: 493-501, 1995
52. Kakiuchi Y, Tsuji S, Tsujii M, Murata H, Kawai N, Yasumaru M, Kimura A, Komori M, Irie T, Miyoshi E, Sasaki Y, Hayashi N, Kawano S, Hori M: Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res 62: 1567-1572, 2002
53. Daniel TO, Liu H, Morrow JD, Crews BC, Marnett LJ: Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 59: 4574-4577, 1999
54. Gately S: The contribution of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 19: 19-27, 2000
55. Oliver L, Cordel S, Barbieux I, LeCabellec MT, Meflah K, Gregoire M, Vallette FM: Resistance to apoptosis is increased during metastatic dissemination of colon cancer. Clin Exp Metastat 19: 175-180, 2002
56. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM: Intracellular unesterfied arachidonic acid signals apoptosis. Proc Natl Acad Sci USA 97: 11280-11285, 2000
57. Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE, Lotan R, Fischer SM, Lippmann SM: 15-LOX-1: A novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst 92: 1136-1142, 2000
58. Jain SK, Peppercorn MA: Inflammatory bowel disease and colon cancer: A review. Dig Dis Sci 15: 243-252, 1997
59. Prescott SM, Fitzpatrick FA: Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 1470: M69-M78, 2000
60. Shacter E, Weitzman SA: Chronic inflammation and cancer. Oncology 16: 230-232, 2002
61. McGinty A, Foschi M, Chang YE, Han J, Dunn MJ, Sorokin A: Induction of prostaglandin endoperoxide synthase 2 by mitogen-activated protein kinase cascades. Biochem J 352: 419-424, 2000
62. Marks F, Furstenberger G: Cancer chemoprevention through interruption of multistage carcinogenesis: The lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer. Eur J Cancer 36: 314-329, 2000
63. Fitzpatrick FA: Inflammation, carcinogenesis, and cancer. Int Immunopharmacol 1: 1651-1667, 2001
64. St Croix B, Rago C, Velculescu VE, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW: Genes expressed in human tumor endothelium. Science 286: 1197-1202, 2000
65. Frame MC: Src in cancer: Deregulation and consequences for cell behavior. Biochim Biophys Acta 1602: 114-130, 2002
66. Licato LL, Brenner DA: Analysis of signaling protein kinases in human colon or colorectal carcinomas. Dig Dis Sci 43: 1454-1464, 1998
67. 2 interacts with v-Src oncoprotein from RSV-transformed hamster cells. J Biol Chem 276: 34006-340012, 2001
68. Shields JM, Pruitt K, McFall A, Shaub A, Der CJ: Understanding Ras: 'It ain't over 'til it's over'. Trends Cell Biol 10: 147-154, 2000
69. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M: Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327: 298-303, 1987
70. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B: Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-297, 1987
71. Kloog Y, Cox AD: RAS inhibitors: Potential for cancer therapeutics. Mol Med Today 6: 398-402, 2000
72. Tsukada K, Tanino M, Soga H, Shimizu N, Shimizu A: Novel Activating Mutation of the K-ras Gene in human primary colon adenocarcinoma. Biochim Biophys Res Commun 278: 653-658, 2000
73. Bockmann B, Grill H, Giesing M: Molecular characterization of minimal residual cancer cells in patients with solid tumors. Biomol Eng 17: 95-111, 2001
74. Araki Y, Nakamura K, Chijiiwa Y, Nawata H: Expression of the placenta-specific, 100kDa ras GTPase activating protein in several human cancer cell lines and normal human tissues. Mol Cell Biochem 175: 195-204, 1997
75. 2 by oncogenic Ras in human non-small cell lung cancer. J Biol Chem 272: 14501-14504, 1997
76. Oliff A: Farnesyltransferase inhibitors: Targeting the molecular basis of cancer. Biochim Biophys Acta 1423: C19-C30, 1999
77. 2 by oncogenic Ras is mediated through the JNK and ERK pathways in rat epithelial cells. J Biol Chem 276: 1226-1232, 2001
78. 2-linked cascade in signaling by an oncogenic, constitutively active Ha-Ras Isoform. J Biol Chem 276: 24645-24653, 2001
79. 2 genes in colorectal adenocarcinomas. Cancer Lett 182: 175-182, 2002
80. 1 in immortalized mouse colonocytes expressing oncogenic Ras. J Gastrointest Surg 6: 304-309, 2002
81. Yuan C, Mandal AK, Zhang Z, Mukherjee AB: Transcriptional regulation of cyclooxygenase-2 gene expression: Novel effects of nonsteroidal anti-inflammatory drugs. Cancer Res 60: 1084-1091, 2000
82. Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL: Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res 62: 625-631, 2002
83. Fournier DB, Gordon GB: COX-2 and colon cancer: Potential targets for chemoprevention. J Cell Biochem 34 (suppl): 97-102, 2000
84. Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV: Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res 60: 293-297, 2000
85. Smith WL, DeWitt DL, Garavito RM: Cyclooxygenases: Structural, cellular, and molecular biology. Annu Rev Biochem 69: 145-182, 2000
86. Giardiello FM, Spannhake EW, Dubois RN, Hylind LM, Robinson CR, Hubbard WC, Hamilton SR, Yang VW: Prostaglandin levels inhuman colorectal mucosa: Effects of sulindac in patients with familial adenomatous polyposis. Dig Dis Sci 43: 311-316, 1998
87. Chithra V, Leelamma S: Coriandrum sativum - effect on lipid metabolism in 1,2-dimethyl hydrazine induced colon cancer. J Ethno-Pharm 71: 457-463, 2000
88. 2 expression in colonic tissue. Cancer Lett 134: 129-139, 1998
89. Nakanishi Y, Kamijo R, Takizawa K, Hatori M, Nagumo M: Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines. Eur J Cancer 37: 1570-1578, 2001
90. Hong J, Smith TJ, Ho C, August DA, Yang CS: Effects of purified green and black tea polyphenols on cyclooxygenase- and lypoxygenase-dependent metabolism of arachidonic acid inhuman colon mucosa and colon tumor tissues. Biochem Pharmacol 62: 1175-1183, 2001
91. Mimori-Kiyosue Y, Tsukita S: Where is APC going? J Cell Biol 154: 1105-1109, 2001
92. 2. J Biol Chem 272: 16069-16072, 1997
93. 2 in fatty acid incorporation, phospholipid remodeling, lysophosphotidylcholine generation, and secretagogue-induced arachadonic acid release in pancreatic islets and insulinoma cells. J Biol Chem 274: 13915-13927, 1999
94. Shen Z, Belinson J, Morton RE, Y X, Y X: Phorbol 12-myristate 13-acetate stimulates lysophosphotidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells. Gynecol Oncol 71: 364-368, 1998
95. 2 blocks phospholipid remodeling in murine P388D1 macrophages. J Biol Chem 272: 29317-29321, 1997
96. Jones PA, Takai D: The role of DNA methylation in mammalian epigenetics. Science 293: 1068-1070, 2001